scholarly journals Is Hydroxychloroquine Safe During Pregnancy? Observations from Penn Medicine

2020 ◽  
Author(s):  
Lena Davidson ◽  
Silvia P. Canelón ◽  
Mary Regina Boland
Keyword(s):  
United States ◽  
World Health Organization ◽  
United States Of America ◽  
The United States ◽  
World Health ◽  
The World ◽  
Novel Coronavirus ◽  
Health Organization

A novel strain of coronavirus appeared in December 2019. Over the next few months, this novel coronavirus spread throughout the world, being declared a pandemic by the World Health Organization on March 11, 2020. As of this writing (March 28, 2020) over one hundred thousand individuals in the United States of America were confirmed cases. One way of treating the associated disease, COVID-19, is to reuse existing FDA-approved medications. One medication that has shown promise is hydroxychloroquine (HCQ). However, the utility and safety of HCQ among pregnant COVID-19 patients remains a concern.

scholarly journals COVID-19 Pandemic: Disparate Health Impact on the Hispanic/Latinx Population in the United States

2020 ◽  
Vol 222 (10) ◽  
pp. 1592-1595 ◽  
Author(s):  
Raul Macias Gil ◽  
Jasmine R Marcelin ◽  
Brenda Zuniga-Blanco ◽  
Carina Marquez ◽  
Trini Mathew ◽  
...  
Keyword(s):  
United States ◽  
Health Disparities ◽  
World Health Organization ◽  
Vulnerable Populations ◽  
Health Impact ◽  
The United States ◽  
World Health ◽  
The World ◽  
Novel Coronavirus ◽  
Health Organization

Abstract In December 2019, a novel coronavirus known as SARS-CoV-2, emerged in Wuhan, China, causing the coronavirus disease 2019 we now refer to as COVID-19. The World Health Organization declared COVID-19 a pandemic on 12 March 2020. In the United States, the COVID-19 pandemic has exposed preexisting social and health disparities among several historically vulnerable populations, with stark differences in the proportion of minority individuals diagnosed with and dying from COVID-19. In this article we will describe the emerging disproportionate impact of COVID-19 on the Hispanic/Latinx (henceforth: Hispanic or Latinx) community in the United States, discuss potential antecedents, and consider strategies to address the disparate impact of COVID-19 on this population.

The Ethics of COVID-19 Vaccine Passports

2021 ◽  
Vol 46 (4) ◽  
pp. 1-2
Author(s):  
Joseph Meaney ◽  
Keyword(s):  
United States ◽  
World Health Organization ◽  
The United States ◽  
Scientific Data ◽  
World Health ◽  
Medical Decisions ◽  
The Poor ◽  
Divided Society ◽  
The World ◽  
Health Organization

COVID-19 vaccine passports run the risk of creating a divided society where social privileges or restrictions based on “fitness” lead to discrimination based on immunization status. Individuals have a strong right to be free of coercion to take a COVID-19 vaccine, and we should be very leery of further invasion of private medical decisions. These concerns are shared both internationally and in the United States, and the World Health Organization, the Biden administration, and many US governors oppose COVID-19 vaccine credentials. In addition, regulations for COVID-19 vaccine credentials face practical barriers, including lack of access globally, especially among the poor; and lack of scientific data on the efficacy of these vaccines.

Letters to the Editors

PEDIATRICS ◽  
1982 ◽  
Vol 69 (4) ◽  
pp. 503-504
Author(s):  
Stuart H. Walker
Keyword(s):  
United States ◽  
Developing Countries ◽  
World Health Organization ◽  
The United States ◽  
World Health ◽  
The World ◽  
Health Organization

My letter1 called attention to the frequency with which in the United States hypernatremia has been associated with the unsupervised administration of solutions containing sodium in amounts as low as 20 to 50 mmoles/liter.2,3 It has not been demonstrated that solutions similar to that recommended by the World Health Organization (80 to 90 mmoles of sodium per liter), designed for supervised use in the management of the infantile diarrheas of developing countries, are safe in unsupervised use in the United States.

scholarly journals Recommendations for Adopting the International Code of Marketing of Breast-milk Substitutes Into U.S. Policy

2017 ◽  
Vol 33 (3) ◽  
pp. 582-587 ◽  
Author(s):  
Jessica Soldavini ◽  
Lindsey Smith Taillie
Keyword(s):  
United States ◽  
Breast Milk ◽  
World Health Organization ◽  
The United States ◽  
World Health ◽  
International Code ◽  
The World ◽  
Breast Milk Substitutes ◽  
Milk Substitutes ◽  
Health Organization

In 1981, the World Health Organization adopted the International Code of Marketing of Breast-milk Substitutes ( International Code), with subsequent resolutions adopted since then. The International Code contributes to the safe and adequate provision of nutrition for infants by protecting and promoting breastfeeding and ensuring that human milk substitutes, when necessary, are used properly through adequate information and appropriate marketing and distribution. Despite the World Health Organization recommendations for all member nations to implement the International Code in its entirety, the United States has yet to take action to translate it into any national measures. In 2012, only 22.3% of infants in the United States met the American Academy of Pediatrics recommendation of at least 6 months of exclusive breastfeeding. Countries adopting legislation reflecting the provisions of the International Code have seen increases in breastfeeding rates. This article discusses recommendations for translating the International Code into U.S. policy. Adopting legislation that implements, monitors, and enforces the International Code in its entirety has the potential to contribute to increased rates of breastfeeding in the United States, which can lead to improved health outcomes in both infants and breastfeeding mothers.

scholarly journals Inclusive Policymaking Tools: A COVID-19 Pandemic Case Study

2020 ◽  
Vol 17 (01) ◽  
Author(s):  
Ans Irfan ◽  
Ankita Arora ◽  
Christopher Jackson ◽  
Celina Valencia
Keyword(s):  
Best Practices ◽  
United States Of America ◽  
The United States ◽  
World Health ◽  
Mortality And Morbidity ◽  
The World ◽  
Novel Coronavirus ◽  
Health Organization ◽  
Equity And Inclusion

World Health Organization (WHO) estimates indicate the United States of America has the highest novel Coronavirus disease (COVID-19) burden in the world, with over 5 million confirmed cases and nearly 165,000 associated deaths as of August 14th, 2020 (WHO 2020). As the COVID-19 mortality and morbidity has disproportionately impacted populations who experience vulnerabilities due to structural issues such as racism (Laurencin and McClinton 2020; Lin II and Money 2020; Martin 2020; Kim et al. 2020), it has become increasingly necessary to take this opportunity and intentionally codify diversity, equity, and inclusion (DEI) practices in the policymaking process. To encourage and facilitate this, we synthesize existing literature to identify best practices that can not only be used to inform COVID-19-related public policy activities but will also continue to inform inclusive policymaking processes in the future. We identify specific tools for policymakers at all levels of government to better operationalize the DEI framework and enact inclusive, equitable public policies as a result.

Sign in / Sign up

Export Citation Format

Share Document